Mercado de control de la natalidad prematuros: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPMD00002026
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 115
Buy Now

Se espera que el mercado mundial de anticonceptivos prematuros alcance los 1.809,0 millones de dólares en 2025 desde los 1.190,5 millones de dólares de 2017. Se estima que el mercado crecerá con una tasa compuesta anual del 4,9% entre 2018 y 2025.

América del Norte es el mercado geográfico más grande y se espera que sea el mayor generador de ingresos durante el período de pronóstico, mientras que se espera que el mercado experimente un crecimiento a un ritmo significativo en la región de Asia Pacífico (APAC) durante el período de pronóstico. Se espera que el mercado de anticonceptivos a término de Asia Pacífico crezca con una tasa compuesta anual del 5,1% a 325,6 millones de dólares en 2025 desde 222,4 millones de dólares en 2017.

 Mercados regionales lucrativos


Perspectivas del mercado

Número creciente de nacimientos prematuros

Ha habido un aumento gradual en el número de nacimientos prematuros en los últimos años. Según la Organización Mundial de la Salud (OMS), el nacimiento prematuro es una de las principales causas de muerte entre niños menores de 5 años. Puede deberse a una inducción temprana del parto o a una cesárea. Los embarazos múltiples, las infecciones y las enfermedades crónicas como la diabetes y la hipertensión arterial son otras causas comunes de partos prematuros. Según los Centros para el Control y la Prevención de Enfermedades (CDC), se observó una reducción en los nacimientos prematuros entre 2007 y 2014. En 2015, el bajo peso al nacer y los nacimientos prematuros representaron alrededor del 17% de las muertes infantiles. Sin embargo, el número aumentó durante 2016, con diferencias raciales y étnicas. En los EE. UU., 1 de cada 10 bebés nacidos fue un parto prematuro.

Iniciativas para la prevención del parto prematuro
Varias organizaciones gubernamentales y no gubernamentales están comprometidas a aumentar la conciencia sobre el parto prematuro en varios países. a traves del globo. Organizaciones como los CDC han implementado estrategias para reducir los nacimientos prematuros. Estas estrategias incluyen la prestación de servicios de atención médica antes y entre embarazos; determinar población en riesgo de parto prematuro y brindar tratamiento inmediato, desalentando partos antes de las 39 semanas sin necesidad médica; y prevenir embarazos no deseados esperando al menos 18 meses entre embarazos.

Marco regulatorio estricto
Las autoridades regulatorias como Food & La Administración de Medicamentos (FDA), la Agencia Europea de Medicamentos (EMA) y otras han mostrado constantemente una postura dura hacia los fabricantes de biotecnología de latas farmacéuticas. Los actores del mercado deben cumplir con los requisitos y directrices de la FDA y otras autoridades reguladoras y deben controlar constantemente los cambios realizados en estas directrices de vez en cuando. Los fabricantes de medicamentos y dispositivos médicos deben cumplir con estas regulaciones relacionadas con las buenas prácticas de fabricación (cGMP) y las buenas prácticas de laboratorio (GLP) vigentes para garantizar el diseño, seguimiento y control adecuados de los procesos e instalaciones de fabricación. Además, cualquier desviación de los protocolos registrados, las exigencias y los requisitos de estas orientaciones conlleva la finalización de los ensayos clínicos realizados por las empresas farmacéuticas.

Además, la FDA también exige un fuerte control de seguridad y un estricto plan de dispensación que debe seguir el fabricante. El incumplimiento por parte de los fabricantes afecta las ventas de los productos en el mercado y puede dar lugar a retiradas de productos comercializados debido a casos registrados por incumplimiento de las promesas en la función y desempeño del producto o terapéutico que puede empañar la reputación de la empresa. arriesgando su crecimiento futuro. En el caso de ensayos clínicos para el desarrollo de terapias anticonceptivas prematuras, la FDA y otros organismos reguladores tienen regulaciones estrictas por lo que a los fabricantes les resulta difícil agrupar a pacientes embarazadas, generando falta de modelos funcionales. Esto, a su vez, da como resultado el rechazo de los ensayos y, por lo tanto, puede actuar como un obstáculo para el crecimiento del mercado.

Información sobre el producto
El mercado de anticonceptivos prematuros por método de tratamiento se segmenta en tratamientos y dispositivos farmacéuticos. El segmento de tratamiento farmacéutico está preparado para crecer con una mayor cuota de mercado del 55,6% en 2017. Se prevé que el mercado de tratamiento farmacéutico aumente durante el período previsto de 2017 a 2025, a un ritmo significativo.

  ;Mercado de control de la natalidad prematuro, por método de tratamiento



Perspectivas estratégicas
Se observaron colaboraciones/adquisiciones como la estrategia más adoptada en el control de la natalidad prematuro a nivel mundial. industria del control de la natalidad. A continuación se enumeran algunos de los lanzamientos de productos y acuerdos realizados por los actores del mercado;

2018: CooperSurgical había adquirido los activos de The LifeGlobal Group y sus afiliados. LifeGlobal Group es un proveedor líder mundial de dispositivos de fertilización in vitro.

Control de natalidad prematuro: SEGMENTACIÓN DEL MERCADO

Por método de tratamiento

  • Dispositivos
  • Cerclaje cervical
  • Pesarios vaginales
  • Tratamiento farmacéutico

Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Reino Unido
  • Asia Pacífico
    • Japón
    • China
    • India
    • < /ul>
    • Medio Oriente y Asia África
      • EAU
      • Arabia Saudita
      • Sudáfrica
    • Sur y África Centroamérica
      • Argentina
      • Brasil

    Perfiles de empresas

     

    • Cooper Surgical
    • Productos Medgyn
    • Integra Life sciences Corporation
    • Panpac Medical Corp.
    • Dr. Arabin GMBH & Co. KG
    • Amag Pharmaceuticals
    • Ben Way Enterprises Sdn Bhd
    • Personal Medical Corp.
    • Bioteque America Inc.
    • Bliss Gvs Pharma Ltd.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

  1. CooperSurgical, Inc.
  2. MEDGYN PRODUCTS, INC.
  3. Integra LifeSciences Corporation
  4. Panpac Medical Corp.
  5. Personal Medical Corp
  6. Bioteque America, Inc.
  7. Bliss GVS Pharma Ltd.
  8. Dr. Arabin GmbH & Co. KG
  9. AMAG Pharmaceuticals
  10. BEN WAY ENTERPRISES SDN BHD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports